GlassScriptPhysician profile
Kelly A Bridges
NPI 1568415768
$4,665.11
in general payments reported to CMS, 2019-2025
39 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $231 · 2021: $309 · 2022: $1,997 · 2023: $790 · 2024: $360 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.02 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,134.07 | 2019-2025 | Lo Loestrin Fe, Orilissa, Qulipta |
| Astellas Pharma US INC | $563.30 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $230.68 | 2019-2023 | Evenity, Prolia |
| Daiichi Sankyo INC. | $205.28 | 2019-2022 | |
| Pfizer INC. | $187.79 | 2019-2024 | |
| Duchesnay USA Incorporated | $111.60 | 2019 | |
| Biogen, INC. | $108.10 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $103.66 | 2019-2025 | Wallach Cryosurgical Equipment, Paragard T 380a |
| Mayne Pharma Commercial LLC | $87.03 | 2022-2025 | |
| Exeltis, USA INC. | $81.62 | 2020-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $72.14 | 2021-2024 | |
| Conmed Corporation | $66.67 | 2023 | Vcare, Airseal |
| Organon LLC | $56.77 | 2022-2024 | Nexplanon |
| Millicent US INC | $49.94 | 2025 | Intrarosa, Femlyv, Femring |
| Optumhealth Care Solutions, LLC | $49.41 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $48.47 | 2019 | |
| Therapeuticsmd, INC. | $44.69 | 2019-2022 | |
| Intuitive Surgical, INC. | $44.58 | 2023 | |
| Sage Therapeutics, LLC | $38.29 | 2022-2024 | |
| Mylan Pharmaceuticals INC. | $30.61 | 2021-2022 | |
| Evofem Biosciences, INC. | $29.43 | 2021 | |
| Gynesonics, INC. | $29.28 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $29.15 | 2019 | |
| Scynexis, INC. | $27.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.00 | 2019 | |
| Baxter Healthcare | $22.30 | 2022 | |
| Sumitomo Pharma America, INC. | $17.50 | 2025 | Myfembree |
| Kci USA, INC. | $17.34 | 2020 | |
| Depuy Synthes Sales INC. | $16.78 | 2024 | Expedium |
| Lupin INC. | $16.47 | 2019 | |
| Abiomed | $15.71 | 2024 | Impella |
| Aspira Women'S Health INC | $15.54 | 2024 | Ova1 |
| Mycovia Pharmaceuticals, INC. | $15.13 | 2022 | |
| Innovation Technologies INC | $14.73 | 2025 | Irrisept |
| Mission Pharmacal Company | $13.44 | 2019 | |
| Roche Diagnostics Corporation | $12.91 | 2019 | |
| Smith+Nephew, INC. | $12.01 | 2022 | |
| Agile Therapeutics, INC. | $11.57 | 2021 | |
| Strongbridge US INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.